Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Gene discovery could curb malaria spread
Only the female mosquito bites people and animals to feed on blood and spread disease.

'Femaleless' gene can be manipulated to prevent female mosquitoes from developing.

Scientists at The Pirbright Institute have discovered a new gene that determines the sex of malaria mosquitoes.

Only the female mosquito bites people and animals to feed on blood and spread disease.
Researchers say the new gene, named femaleless, can be manipulated to prevent female mosquitoes from developing - and could therefore provide a new means for the genetic control of mosquito populations. 

The study was led by scientists from the Vector Molecular Biology Group and published in Current Biology

In the study, researchers first identified femaleless in the mosquito Anopheles gambiae, a primary malaria carrier in Africa. Their experiments revealed that by decreasing the gene expression in mosquito eggs, females develop a more male-like appearance and cannot mate or feed on blood. 

The scientists also discovered that femaleless is exclusive to mosquito species belonging to the genus Anopheles, which is solely responsible for transmitting human malaria. The gene was detected in all Anopheles species studied, and its genetic sequence proved to be similar in different species. 

Dr Jaroslaw Krzywinski, head of the Vector Molecular Biology Group at Pirbright, explains: “We first investigated femaleless because we suspected it would have a role in sex determination, but it was unexpected that knockdown of the gene’s expression would lead to female lethality. 

“This gene is highly conserved in sequence and function in various Anopheles species and, as such, provides an excellent universal target to eliminate females of major malaria vector species, enabling the control of their populations. We hope that this discovery could help us to tackle one of the most devastating insect-borne diseases in the world.”

According to the World Health Organisation, there were an estimated 229 million clinical cases of malaria in 2019 and more than 400,000 deaths globally. Children under five are the most vulnerable group affected by the disease, accounting for 67 per cent of all malaria deaths in 2019. 

Become a member or log in to add this story to your CPD history

Applications open for MMI research grants

News Story 1
 RCVS' Mind Matters Initiative (MMI) has launched round two of its veterinary mental health research grants.

Researchers have until 11.59pm on Wednesday, 28 May 2025 to apply for a grant for research which reflects MMI's 2025 focus areas.

Only one Impact Grant was awarded last year, and so this year there are two Discovery Grants and one Impact Grants available. Each Discovery Grant is worth £5,000 and the Impact Grant is worth £15,000.

For more information or to apply, email researchgrants@rcvs.org.uk to contact the MMI team.

 

Click here for more...
News Shorts
BBC Radio 4 documentary addresses corporate fees

BBC Radio 4's File on 4 Investigates has released a documentary exploring how corporate-owned veterinary practices may be inflating bills to increase profit.

Released on 15 April, 'What's Happening To Your Vet Bills?' revealed the policies which many corporate groups have in place to increase their profits. This included targets and upgrades which veterinary teams are tasked with meeting on a regular basis.

It also features Anrich Vets, an independently-owned practice based in Wigan. Following the case of Staffordshire terrier Benjy, who is diagnosed with a tumour, the documentary shares how the team were able to offer contextualised care and advice to make the procedure as affordable as possible for his owners.

The documentary can be heard on demand on BBC iPlayer.